Indefinite Delivery Contract 36E79725D0005

Award Date 3/15/25
Last Date to Order 3/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Seqirus USA Inc. for the procurement of Influenza Virus Vaccines for the 2025-2026 flu season. The $51.6 million contract has a period of performance from March 15, 2025, to March 14, 2026, and will provide vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health...
The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
The IDV award provides Sanofi Pasteur Inc. with an IDIQ contract vehicle to supply influenza virus vaccines and related services to federal agencies through 2024. Task orders issued to date involve delivery of vaccines by the prime contractor to locations of the Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, and other government customers. Performance spans multiple years at places including Swiftwater, PA, with total task order obligations approaching $80 million. The...
This IDV contract, awarded by the Defense Logistics Agency Troop Support, is for the supply of approximately 3.35 million doses of injectable influenza vaccine for the 2025-2026 flu season. The contract is a single-award indefinite quantity vehicle with a ceiling value of $25,058,634.80 and a period of performance through February 13, 2026. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sanofi Pasteur Inc. for the supply of influenza vaccines. Task orders issued by VA, Federal Bureau of Prisons, Indian Health Service, and Department of Health and Human Services procure influenza virus vaccines in pre-filled syringes and multi-dose vials for individuals over 18 years old. Additional line items provide syringes tailored for those 65 and older as well as children ages 36...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult influenza vaccines for the 2022-2023 flu season. The contract has a ceiling value of $65,825,903.80 and a period of performance from the date of award on December 31, 2021 through February 28, 2023. The original solicitation sought proposals for IDIQ contracts to supply a minimum of 100 doses and a maximum of 20 million doses of...
The Department of Veterans Affairs National Acquisition Center awarded a single award IDV to Seqirus USA Inc. on March 15, 2021 with a potential value of $67,604,685.53. Task orders issued against the IDV by the VA, Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Healthcare Center procure influenza virus vaccines for the 2021-2022 season. Vaccines provided under the IDV and related task orders include those in multi-dose vials and single dose syringes for adults and...
The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. The 5-year single-award IDV, valued at up to...

The Indefinite Delivery Contract (IDC) awarded to Sanofi Pasteur Inc. by the National Acquisition Center, a component of the Department of Veterans Affairs (VA), is for the procurement of Influenza Virus Vaccine for the 2025-2026 influenza season. The contract has a Period of Performance from March 15, 2025 to March 14, 2026, and a ceiling value of $113,670.50. As the prime contractor, Sanofi Pasteur Inc. will provide seasonal influenza vaccines to support requirements for the VA, State Veteran Homes Option 2 (SVH2), Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center (FHCC). The evaluation and award will be made by solicitation line item, with estimated annual usage ranging from 1,462 to 153,504 units across various vaccine presentations. The contract is an unrestricted procurement with no set-aside designation, leveraging Sanofi Pasteur's manufacturing capabilities and distribution infrastructure to facilitate efficient fulfillment of agency requirements for vaccines supporting public health missions.

The original pre-solicitation notice indicates that the VA National Acquisition Center intends to issue a Request for Proposal (RFP) for the Influenza Virus Vaccine procurement, with an estimated solicitation release date of September 18, 2024 and a closing date of October 2, 2024. The first shipment of the vaccine must be at least 50% of each facility's ordered quantity and delivered between August 15 and September 15, 2025, with the remaining quantity delivered between September 16 and October 15, 2025. FHCC will receive 100% of the awarded quantities between August 15 and September 15, 2025.

Generated 1/30/25, 9:03 AM